Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Evaluation of the Role of Cisplatin-conjugated-soluble Gelatin Sponge: Feasibility Study in a Swine Model

Journal Article · · Cardiovascular and Interventional Radiology
; ; ; ; ; ; ;  [1]; ;  [2]
  1. Wakayama Medical University, Department of Radiology (Japan)
  2. Central Research Institute, Jellice Co., Ltd (Japan)

PurposeTo evaluate the safety and the delivery function of cisplatin-conjugated-soluble gelatin sponge in a swine model.MethodsFifteen healthy young swine were assigned into three groups: transarterial cisplatin infusion group, transarterial chemoembolization (TACE) with cisplatin-conjugated 120-min soluble gelatin sponge (TACE-120) group, and TACE with cisplatin-conjugated 360-min soluble gelatin sponge (TACE-360) group. A total volume of 0.8 mL/kg cisplatin in each group and 8 mg/kg soluble gelatin sponge in TACE-120 and TACE-360 groups were injected from the left hepatic artery in small increments for 10 min. Common hepatic angiography and whole-blood sampling via the left hepatic vein were conducted to explore recanalization immediately after the procedure and again at 10, 30, 60, 90, 120, 180, 240, 300, 360, and 420 min later. The area under the plasma concentration curve (AUC) of non-protein-bound platinum was compared among the three groups. Each liver was removed and cut into 10-cm-thick sections for calculating liver-damaged volume ratio.ResultsSequential angiography depicted gradual recanalization of the occluded hepatic artery and total recanalization at 120 and 360 min after embolization in the TACE-120 and TACE-360 groups, respectively. Of the three groups, AUC{sub 0-30}, AUC{sub 30-120}, and AUC{sub 120-420} were significantly highest in the transarterial cisplatin infusion group (p < 0.001), the TACE-120 group (p < 0.001), and the TACE-360 group (p < 0.001), respectively. The liver-damaged volume ratio in the TACE-360 group was small (8.20 %) but significantly higher than that in the TACE-120 group (2.67 %, p = 0.014).ConclusionCisplatin-conjugated soluble gelatin sponge functions as a cisplatin carrier and is associated with tolerable liver damage.

OSTI ID:
22121749
Journal Information:
Cardiovascular and Interventional Radiology, Journal Name: Cardiovascular and Interventional Radiology Journal Issue: 4 Vol. 36; ISSN 0174-1551; ISSN CAIRDG
Country of Publication:
United States
Language:
English

Similar Records

Transarterial Chemoembolization Using Cisplatin Powder in a Rabbit Model of Liver Cancer
Journal Article · Mon Sep 15 00:00:00 EDT 2008 · Cardiovascular and Interventional Radiology · OSTI ID:21450335

Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model
Journal Article · Wed Mar 15 00:00:00 EDT 2017 · Cardiovascular and Interventional Radiology · OSTI ID:22645309

A New Soluble Gelatin Sponge for Transcatheter Hepatic Arterial Embolization
Journal Article · Tue Dec 14 23:00:00 EST 2010 · Cardiovascular and Interventional Radiology · OSTI ID:21428886